Peritoneal drainage as a treatment for malignant ascites: a literature review
DOI:
https://doi.org/10.15649/cuidarte.919Keywords:
Peritoneal Drainage, Ascites, Neoplasms, Palliative CareAbstract
Introduction: Malignant ascites is the abnormal accumulation of fluid in the peritoneal cavity as a consequence of pathologies such as cancer. It is also a trigger factor for a symptom cluster (pain, dyspnea, loss of appetite, nausea, reduced mobility and changes in physical appearance) that becomes a clinical problem that is difficult to deal with. One of the treatments aimed at improving this condition is the therapeutic paracentesis, a medical procedure that uses a drainage technique that sometimes requires repeated practice. It can be a refractory symptom that leads to the requirement of the implantation of a peritoneal catheter as a palliative measure to improve the quality of life of patients and their family. Materials and Methods: A review of the existing literature was carried out in which an initial search was established obtaining 747 articles, of which 277 were classified as potentially relevant, which were later verified to meet the inclusion criteria. After filtering information and deleting duplicated articles, 8 studies were included in the literature review as they were found to meet all these parameters. Results: The peritoneal catheter technique is 100% successful without immediate complications, being an optimal palliative measure for patients with refractory ascites as it ensures device durability greater than 30 days. In addition, it is easy to use by professionals, patients and families, which allows outpatient management reducing costs, readmissions for late complications that are potentially preventable and identifiable such as filtration, displacement, infections, occlusion of the device, and hospital complications, which provide immediate comfort and symptom control. Discussion and Conclusions: Based on the results obtained in this review, the optimal peritoneal catheter is defined is as a palliative measure in the treatment of malignant ascites symptoms triggered in patients with advanced oncological pathologies, allowing an improvement in the quality of life of people.
Como citar este artículo: Fiscal LM, Salazar VE, Oviedo CP, Gavilán DM, Carmona X. Drenaje peritoneal como tratamiento de la ascitis maligna, una revisión de la literatura. Rev Cuid. 2020; 11(1): e919. http://dx.doi.org/10.15649/cuidarte.919
References
Taber CW. Taber’s cyclopedic medical dictionary. Philadelphia: FA Davies Co; 1965.
Castano MA, Fletcher AV. Terapia intraperitoneal paliativa en ascitis maligna refractaria. Revista Colombiana de Cancerología. 2018; 22(1): 18-38. https://doi.org/10.1016/j.rccan.2017.01.001
Guillén MC, Plancarte RS, Reyes D, Guajardo J, Chejne F. Manejo Paliativo de la Ascitis en Pacientes Oncológicos. 2008; Cancerología. (3): 149-57.
Kuemmerle JF. Enfermedades inflamatorias y anatómicas del intestino, el peritoneo, el mesenterio y el Epiplón: Carcinomatosis peritoneal y ascitis maligna. In: Goldman L, Schafer AI, editors. Goldman- Cecil. Tratado de medicina interna. 25th ed. España: Elsevier; 2017.
Plancarte R, Guillén MR, Guajardo J, Mayer F. Ascitis en los pacientes oncológicos: Fisiopatogenia y opciones de tratamiento. Revista de la Sociedad Española del Dolor. 2004; 11(3):156-62.
Sangisetty SL, Miner TJ. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World journal of gastrointestinal surgery. 2012; 4(4): 87-95. https://doi.org/10.4240/wjgs.v4.i4.87
Christensen L, Wildgaard L, Wildgaard K. Permanent catheters for recurrent ascites--a critical and systematic review of study methodology. Supportive Care in Cancer. 2016; 24(6): 2767-79. https://doi.org/10.1007/s00520-016-3145-y
Fleming N, Alvarez-Secord A, Von Gruenigen V, J Miller M, Abernethy A. Indwelling Catheters for the Management of Refractory Malignant Ascites: A Systematic Literature Overview and Retrospective Chart Review. Journal of Pain and Symptom Management. 2009; 38(3): 341-9. https://doi.org/10.1016/j.jpainsymman.2008.09.008
Caldwell J, Edriss H, Nugent K. Chronic peritoneal indwelling catheters for the management of malignant and nonmalignant ascites. Baylor University Medical Center Proceedings. 2018; 31(3): 297-302. https://doi.org/10.1080/08998280.2018.1461525
Urrútia G, Bonfill X. Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Medicina Clínica 2010;135(11):507-511. https://doi:10.1016/j.medcli.2010.01.015
Vandenbroucke JP, Von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Mejorar la comunicación de estudios observacionales en epidemiología (STROBE): explicación y elaboración. Gaceta Sanitaria 2009;23(2):158.e1-158.e28. https://doi:10.1016/j.gaceta.2008.12.001
Meier M, Mortensen FV, Madsen HHT. Malignant ascites in patients with terminal cancer is effectively treated with permanent peritoneal catheter. Acta Radiologica Open. 2015; 4(7): 1-7. https://doi.org/10.1177/2058460115579934
Sales P, Calsina-Berna A, López M, Cabrera M, Poyato E, Grimau I. Estudio descriptivo sobre el uso de catéteres peritoneales en el manejo de la ascitis maligna. Medicina Paliativa. 2012; 19(1): 38-44. https://doi.org/10.1016/j.medipa.2010.12.001
Saiz-Mendiguren R, Gómez-Ayechu M, Noguera JJ, García-Lallana A, Marginet C, Cano D, et al. Drenaje permanente tunelizado de la ascitis maligna: experiencia inicial con el catéter PleurX®. Radiología. 2010; 52(6): 541-5. https://doi.org/10.1016/j.rx.2010.06.005
Wong BCT, Cake L, Kachuik L, Amjadi K. Indwelling Peritoneal Catheters for Managing Malignancy-Associated Ascites. Journal of Palliative Care. 2015; 31(4): 243-9. https://doi.org/10.1177/082585971503100406
Bohn KA, Ray CE. Repeat Large-Volume Paracentesis Versus Tunneled Peritoneal Catheter Placement for Malignant Ascites: A Cost-Minimization Study. American Journal of Roentgenology. 2015; 205(5): 1126-34. https://doi.org/10.2214/AJR.15.14484
Akinci D, Erol B, Ciftci T, Akhan O. Radiologically placed tunneled peritoneal catheter in palliation of malignant ascites. Eur J Radiol. 2011; 80(2): 265-8. https://doi.org/10.1016/j.ejrad.2010.06.047
Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Annals of Oncology. 2007; 18(5): 945-9. https://doi.org/10.1093/annonc/mdl499
Abdel MK, Hassan MS, Mostafa MY. Value of implantable peritoneal ports in managing recurrent malignant ascites. The Egyptian Journal of Radiology and Nuclear Medicine. 2014; 45(2): 417-22. https://doi.org/10.1016/j.ejrnm.2014.02.001
Sartori S, Nielsen I, Trevisani L, Tassinari D, Ceccotti P, Barillani M, et al. Sonographically Guided Peritoneal Catheter Placement in the Palliation of Malignant Ascites in End-Stage Malignancies. Am J Roentgenol. 2002; 179(6): 1618-20. https://doi.org/10.2214/ajr.179.6.1791618
Knight JA, Thompson SM, Fleming CJ, Bendel EC, Neisen MJ, Neidert NB, et al. Safety and Effectiveness of Palliative Tunneled Peritoneal Drainage Catheters in the Management of Refractory Malignant and Non-malignant Ascites. Cardiovasc Intervent Radiol. 2018; 41(5): 753-61. https://doi.org/10.1007/s00270-017-1872-1
American Society of Clinical Oncology. Líquido en el abdomen o ascitis [Internet]. 2012. [Consultado 8 junio 2019]; Disponible en: https://www.cancer.net/es/asimilaci%C3%B3n-con-c%C3%A1ncer/efectos-f%C3%ADsicos-emocionales-y-sociales-del-c%C3%A1ncer/manejo-de-los-efectos-secundarios-f%C3%ADsicos/l%C3%ADquido-en-el-abdomen-o-ascitis
National Cancer Institute. Estadísticas del cáncer. [Internet]. 2015; [Consultado 8 junio 2019] Disponible en: https://www.cancer.gov/espanol/cancer/naturaleza/estadisticas
Alfaro M, Carmona X, Montes B, Mujica I, Parra D. Manejo del Catéter Peritoneal de la Persona con Ascitis refractaria en Enfermería en Cuidados Paliativos. [Internet]. [Consultado 8 junio 2019]. Disponible en: https://cuidadospaliativos.org/uploads/2017/5/Manejo%20del%20cate%CC%81ter%20Peritoneal%20de%20la%20persona%20con%20ascitis%20refractaria%20en%20Enfermeria%20en%20Cuidados%20Paliativos.pdf
Published
How to Cite
Issue
Section
Altmetrics
Downloads
License
Journal Cuidarte, scientific publication of open access, is licensed under a Creative Commons Attribution (CC BY-NC), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Any other form of use such as reproduction, transformation, public communication or distribution, for profit, requires the prior authorization of the University of Santander UDES.
The names and e-mail addresses entered in the Journal Cuidarte will be used exclusively for the purposes stated by this magazine and will not be available for any other purpose or other person.
The articles published in the Journal Cuidarte represent the criteria of their authors and do not necessarily constitute the official opinion of the University of Santander UDES.
